BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the most profitable biotech stocks to buy. Wells Fargo maintained a Buy rating on BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) on October 21 and set a price target of $90. BioMarin Pharmaceutical Inc. (BMRN): Among Small-Cap Healthcare Stocks Hedge Funds is Buying Similarly, Morgan Stanley analyst Sean Laaman also maintained a bullish stance on the stock on October 19, assigning it a Buy rating and a$104 price target. Laaman stated that BioMarin Pharma ...